Mayo Clinic is one of the world’s leading medical schools, and in the past few years, its graduates have become the best-trained and brightest in the world.
Now, a team of researchers has discovered that one of its graduates had a condition called Parkinson’s Disease (PD), and it has shown in the lab that it can lead to severe and disabling symptoms.
The Mayo Clinic team, led by Dr. Mark Schmuerer, MD, PhD, from the Department of Otolaryngology, Head and Neck Surgery, is currently conducting clinical trials with PD patients.
Dr. Schmuesrer said that the Mayo Clinic study is the first to definitively show PD in a patient, and the first study to look at PD patients at an early stage of the disease.
“This study is not only about our patients; it is about the whole world,” Dr. Schmeuer said.
“I think that this is really important because it is not just the Mayo team, it is the entire world.
It shows us the potential of PD to be a very important intervention in treating this condition.”
The Mayo team found that patients with PD had worse quality of life and quality of daily living, as well as poorer quality of cognition, memory, language and motor function.
“There’s no doubt that PD is a very serious disease, but we’re seeing more and more evidence that it has serious side effects,” Dr Schmoeser said.
In the Mayo study, the Mayo researchers were looking at a group of patients who had been diagnosed with PD, but had been on medication to help them get around.
The team noticed that patients who were on medication were also more likely to have symptoms of the condition, such as depression, fatigue, anxiety and social isolation.
“I think the first question that we should ask ourselves is: Why are we doing this?
Is this a way to control PD, is this a strategy to manage PD, or is it something that is being done to prevent PD?”
Dr. D’Souza said.
“Our goal is to see if there are any treatment options out there that could help these patients.
We’re hoping that we can identify one or two that might be effective, and if we can find one, we would like to pursue that avenue of treatment.”
Dr. D’,Souzeas team is currently working with PD sufferers at the Mayo Children’s Hospital in Rochester, Minnesota, and other Mayo Clinic clinics.
The Mayo Clinic has received grant support from the National Institutes of Health, as part of the National Center for Advancing Translational Sciences (NCATS) to conduct this research.
The study was funded by the National Institute of Neurological Disorders and Stroke, the Department for Health and Human Services, the National Science Foundation and the National Health Service Foundation (HHSF) to the University of Rochester and Mayo Clinic.
About Mayo ClinicThe Mayo clinic is one the largest medical schools in the United States and the fifth-largest in the country.
The hospital is renowned for its world-class medical education, innovative research and care for its patients, as evidenced by its national reputation for high standards of care, high patient satisfaction and strong relationships with the communities we serve.
Mayo Clinic offers a broad range of services to more than 12,000 patients in its community of more than 7,000 physicians, scientists, nurse practitioners and other health care professionals.
For more information, visit www.mayoclinic.org.
Follow us on Facebook and Twitter for more stories from New Zealand.